Agency approved Imbruvica for patients with mantle cell lymphoma, an aggressive form of blood cancer.
The agency cleared Gazyva to fight chronic lymphocytic leukemia in combination with chemotherapy.
Agency approves first single-ingredient hydrocodone drug, despite negative expert opinion.
The U.S. Federal Drug Administration asked owners and vets to report problems.
Biotech drug from Roche offers earlier approach against one of the deadliest forms of the disease.
The drug could cure early stage breast cancer.
The FDA has received seven reports involving patients who received steroid injections from Main Street Family Pharmacy.
Largest financial penalty against a generic maker for Federal Food, Drug and Cosmetic Act violations.
A government appeal of a ruling giving women of all ages access to morning-after birth control is frivolous, a judge said.
A wave of inspections comes in the wake of a nationwide fungal meningitis outbreak last year tied to contaminated drugs from a Massachusetts pharmacy.
